October 18, 2021 by Tom Roberts, Esq.
Hazards of creating pathogens - SARS
In 2015 scientists sent people into caves to gather a RsSHC014-CoV from Chinese horseshoe bats – where the threat of spread to humans was minimal. They brought it back to the lab, created Frankenmice with human lung tissue to amplify and build a chimeric virus encoding a new “novel” zoonotic CoV spike protein from the RsSHCO14-COV sequence that they isolated from the Chinese horseshoe bats. They were exited that they were able to amplify the virus concluding “To extend these findings, primary human airways epithelial (HAE) cultures were infected and showed robust replication of both viruses. Together, the data confirm the ability of viruses with the SHCO14 spike to infect human airway cells and underscore the potential threat of cross-species transmission of SHC014-CoV.” National Public Health 26552008
In 2015 - Gain-Of-Function Research Questioned
In 2015 VICE sounding the warning wrote – – According to [Dr. Ralph Baric, a professor of epidemiology at the University of North Carolina, Chapel Hill], the risk of “gain-of-function” research is worth it. The findings could provide a way to create vaccines and immunotherapy treatments before the next epidemic strikes. Because we have identified both SARS and SHC014-CoV, it’s now possible to develop vaccines that could target those viruses and the viruses that share commonalities between them. In other words, the new findings may help develop vaccines for many more strains of infectious diseases even though we haven’t identified them yet.
Who were these scientists?
Ralph S Baric
Department of Epidemiology, Department of Microbiology and Immunology, University of North Carolina at Chapel Hill
Vineet D Menachery
Department of Epidemiology, University of North Carolina at Chapel Hill
Boyd L Yount, Jr.
Department of Microbiology and Immunology, University of North Carolina at Chapel Hill
Key Laboratory of Special Pathogens and Viosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China.
Key Laboratory of Special Pathogens and Viosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China. Shi directs the Center for Emerging Infectious Diseases at the Wuhan Institute of Virology.
Category General | Tags: anthony fauci, boyd yount, Chapel Hill, Chiese Academy of Sciences, Department of Epidemiology at Chapel HIll, Department of Microbiology and Immunology University of North Carolina at Chapel Hill, gain of function, gain of function research, ralph baric, sars, vineet menachery, Wuhan Institute of Virology, xing-yi ge, zhengli-li shi
Sorry, comments are closed.